Iżrael - Ingliż - Ministry of Health

unipharm ltd, israel - atomoxetine as hydrochloride - coated tablets - atomoxetine as hydrochloride 100 mg - atomoxetine - atomic is indicated for the treatment of attention-deficit/hyperactivity disorder (adhd) in children of 6 years and older, in adolescents and in adults as part of a comprehensive treatment programme. treatment must be initiated by a specialist in the treatment of adhd, such as a paediatrician, child/adolescent psychiatrist, or psychiatrist. diagnosis should be made according to current dsm criteria or the guidelines in icd. in adults, the presence of symptoms of adhd that were pre-existing in childhood should be confirmed. third-party corroboration is desirable and atomic should not be initiated when the verification of childhood adhd symptoms is uncertain. diagnosis cannot be made solely on the presence of one or more symptoms of adhd.based on clinical judgment, patients should have adhd of at least moderate severity as indicated by at least moderate functional impairment in 2 or more settings (for example, social, academic, and/or occupational functioning), affecting several aspects of an individual’s life.

Iżrael - Ingliż - Ministry of Health

unipharm ltd, israel - atomoxetine as hydrochloride - coated tablets - atomoxetine as hydrochloride 18 mg - atomoxetine - atomic is indicated for the treatment of attention-deficit/hyperactivity disorder (adhd) in children of 6 years and older, in adolescents and in adults as part of a comprehensive treatment programme. treatment must be initiated by a specialist in the treatment of adhd, such as a paediatrician, child/adolescent psychiatrist, or psychiatrist. diagnosis should be made according to current dsm criteria or the guidelines in icd. in adults, the presence of symptoms of adhd that were pre-existing in childhood should be confirmed. third-party corroboration is desirable and atomic should not be initiated when the verification of childhood adhd symptoms is uncertain. diagnosis cannot be made solely on the presence of one or more symptoms of adhd.based on clinical judgment, patients should have adhd of at least moderate severity as indicated by at least moderate functional impairment in 2 or more settings (for example, social, academic, and/or occupational functioning), affecting several aspects of an individual’s life.

Iżrael - Ingliż - Ministry of Health

unipharm ltd, israel - atomoxetine as hydrochloride - coated tablets - atomoxetine as hydrochloride 80 mg - atomoxetine - atomic is indicated for the treatment of attention-deficit/hyperactivity disorder (adhd) in children of 6 years and older, in adolescents and in adults as part of a comprehensive treatment programme. treatment must be initiated by a specialist in the treatment of adhd, such as a paediatrician, child/adolescent psychiatrist, or psychiatrist. diagnosis should be made according to current dsm criteria or the guidelines in icd. in adults, the presence of symptoms of adhd that were pre-existing in childhood should be confirmed. third-party corroboration is desirable and atomic should not be initiated when the verification of childhood adhd symptoms is uncertain. diagnosis cannot be made solely on the presence of one or more symptoms of adhd.based on clinical judgment, patients should have adhd of at least moderate severity as indicated by at least moderate functional impairment in 2 or more settings (for example, social, academic, and/or occupational functioning), affecting several aspects of an individual’s life.

Iżrael - Ingliż - Ministry of Health

unipharm ltd, israel - candesartan cilexetil; hydrochlorothiazide - tablets - hydrochlorothiazide 12.5 mg; candesartan cilexetil 16 mg - candesartan - essential hypertension, where monotherapy with candesartan cilexetil or hydrochlorothiazide is not sufficient

Iżrael - Ingliż - Ministry of Health

unipharm ltd, israel - donepezil hydrochloride - tablets - donepezil hydrochloride 10 mg - treatment of mild to moderately severe alzheimer`s dementia.

Iżrael - Ingliż - Ministry of Health

unipharm ltd, israel - cilazapril - tablets - cilazapril 2.5 mg - cilazapril - cilazapril - a blood pressure lowering agent. chronic heart failure.

Iżrael - Ingliż - Ministry of Health

unipharm ltd, israel - cilazapril - tablets - cilazapril 5 mg - cilazapril - cilazapril - a blood pressure lowering agent. chronic heart failure.

Iżrael - Ingliż - Ministry of Health

unipharm ltd, israel - cilazapril - tablets - cilazapril 1 mg - cilazapril - cilazapril - a blood pressure lowering agent.chronic heart failure.

Iżrael - Ingliż - Ministry of Health

unipharm trading ltd, israel - haloperidol as decanoate - solution for injection - haloperidol as decanoate 100 mg/ml - haloperidol - haloperidol - indicated for the maintenance treatment of schizophrenia and schizoaffective disorder in adult patients currently stabilized with oral haloperidol..

Iżrael - Ingliż - Ministry of Health

unipharm ltd, israel - bisoprolol fumarate - tablets - bisoprolol fumarate 5 mg - bisoprolol - bisoprolol - management of angina pectoris, hypertention. treatment of stable chronic, moderate to severe heart failure with impaired systolic ventricular function ( ejection fraction < 35 %, determined by echocardiography) in addition to ace inhibitors and diuretics, and optionally cardiac glycosides.